Salem Investment Counselors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $71.1K | Sell |
566
-1
| -0.2% | -$126 | ﹤0.01% | 524 |
|
|
2025
Q1 | $77.6K | Hold |
567
| – | – | ﹤0.01% | 494 |
|
|
2024
Q4 | $86.7K | Hold |
567
| – | – | ﹤0.01% | 480 |
|
|
2024
Q3 | $110K | Hold |
567
| – | – | ﹤0.01% | 444 |
|
|
2024
Q2 | $131K | Sell |
567
-91
| -14% | -$21.1K | ﹤0.01% | 407 |
|
|
2024
Q1 | $142K | Hold |
658
| – | – | ﹤0.01% | 404 |
|
|
2023
Q4 | $170K | Buy |
658
+50
| +8% | +$12.9K | 0.01% | 369 |
|
|
2023
Q3 | $156K | Buy |
608
+1
| +0.2% | +$257 | 0.01% | 363 |
|
|
2023
Q2 | $173K | Hold |
607
| – | – | 0.01% | 345 |
|
|
2023
Q1 | $169K | Buy |
607
+41
| +7% | +$11.4K | 0.01% | 362 |
|
|
2022
Q4 | $157K | Hold |
566
| – | – | 0.01% | 358 |
|
|
2022
Q3 | $151K | Hold |
566
| – | – | 0.01% | 342 |
|
|
2022
Q2 | $115K | Hold |
566
| – | – | 0.01% | 395 |
|
|
2022
Q1 | $119K | Sell |
566
-51
| -8% | -$10.7K | ﹤0.01% | 398 |
|
|
2021
Q4 | $148K | Buy |
617
+592
| +2,368% | +$142K | 0.01% | 404 |
|
|
2021
Q3 | $7K | Hold |
25
| – | – | ﹤0.01% | 802 |
|
|
2021
Q2 | $9K | Hold |
25
| – | – | ﹤0.01% | 725 |
|
|
2021
Q1 | $7K | Sell |
25
-1
| -4% | -$280 | ﹤0.01% | 719 |
|
|
2020
Q4 | $6K | Sell |
26
-71
| -73% | -$16.4K | ﹤0.01% | 686 |
|
|
2020
Q3 | $28K | Hold |
97
| – | – | ﹤0.01% | 449 |
|
|
2020
Q2 | $26K | Hold |
97
| – | – | ﹤0.01% | 455 |
|
|
2020
Q1 | $31K | Hold |
97
| – | – | ﹤0.01% | 389 |
|
|
2019
Q4 | $29K | Buy |
+97
| New | +$29K | ﹤0.01% | 443 |
|
|
2017
Q3 | – | Sell |
-9
| Closed | -$2K | – | 572 |
|
|
2017
Q2 | $2K | Buy |
+9
| New | +$2K | ﹤0.01% | 565 |
|